Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders

Detalles Bibliográficos
Autores principales: Harrington, Patrick, Kurshan, Ashwini, Delord, Marc, Lechmere, Thomas, Sheikh, Amna, Saunders, Jamie, Saha, Chandan, Dillon, Richard, Woodley, Claire, Asirvatham, Susan, Curto-Garcia, Natalia, Sullivan, Jennifer O’, Kordasti, Shahram, Radia, Deepti, McLornan, Donal, Malim, Michael H., Harrison, Claire, Doores, Katie J., de Lavallade, Hugues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472701/
https://www.ncbi.nlm.nih.gov/pubmed/36083126
http://dx.doi.org/10.1182/bloodadvances.2022008375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472701/
https://www.ncbi.nlm.nih.gov/pubmed/36083126
http://dx.doi.org/10.1182/bloodadvances.2022008375

Ejemplares similares